ISPE

FEBRUARY 7, 2023

The two-day conference on 31 January–1 February featured a range of sessions on topics including biomanufacturing, cell and gene therapy, digital transformation and Pharma 4.0™, Hartman noted the importance of attendees’ work in bringing pharmaceuticals to patients. ™, emerging technologies, and facility design and construction.

Vaccines 88

Vaccines Dosage Hospitals 88

ISPE

NOVEMBER 23, 2022

Development of the Regulatory and Quality track was led by Ciby Abraham, Senior Director and Group Manager, Project and Product Leadership, AstraZeneca who is a member of the RQHC North America Regional Group; and Connie Langer, CMC-Global Regulatory, Pfizer, who is a member of the PQLI Committee’s Q12 Implementation team.

FDA 52

FDA Documentation 52

ISPE

AUGUST 1, 2023

As a distinguished member of the pharmaceutical industry, you wouldn't want to miss this exciting event. Dive into the conference agenda for more inspiring workshops and sessions across various relevant topics. as they share insights on "Pursue of Excellence in Pharmaceutical Therapy."

52

52

European Pharmaceutical Review

OCTOBER 2, 2023

Uniting the global supply chain CPHI Barcelona serves as a vital platform for unrivalled networks and access to the global supply chain. Supply Chain Excellence 8. patient‑centric development, creating a circular economy, quality management fundamentals, and hiring for diversity. Sustainability 9.

Packaging 102

Packaging 102

ISPE

JULY 19, 2023

has taken on significantly increasing momentum in the pharmaceutical industry. SmartFacturing Michelangelo Canzoneri, Global Head of Group Smart Manufacturing at Merck KGaA, Darmstadt, Germany, opened his keynote “SmartFacturing” by asking how we should manage the new normal. and management communication strategy.

Documentation 98

Documentation FDA Labelling Communication 98

ISPE

NOVEMBER 10, 2022

So called “personalized” treatments with cell therapy include taking cells from a patient, performing the genetic manipulation, and then putting them back into the same patient (autologous); another approach involves supplying modified cells to a pool of patients with a related makeup and disorder (allogeneic). Shin Kawamata, MD, PhD.

Documentation 98

Documentation Compounding Hospitals Immunization 98

ISPE

OCTOBER 28, 2022

The conference focused on the ongoing development and growth in these technologies, and featured speakers on a broad range of topics, including advanced manufacturing and how lessons learned from COVID-19 vaccine development can apply to biologics development. Bam said, “We hope to make supply chains completely agile!”.

Vaccines 52

Vaccines FDA Immunization 52

ISPE

SEPTEMBER 11, 2023

Cauchon, PhD 1 September 2023 The biopharmaceutical industry must develop and implement innovative ways of working to be effective and efficient in the current healthcare ecosystem, in which high-quality medicines, adaptability, and assurance of supply are of critical importance.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

PharmaShots

FEBRUARY 27, 2023

After the auspicious start, the chairman of global PHT – Dr. Jagadeesh Babu Rangisetty (CEO – Biophore India Pharmaceuticals, India), and the convenor Dr. Upendra Nagaich (National Secretary – SPER, India) gave the conference opening remarks. So, to summarise I hope that the future will be organized to manage such crisis.

Packaging 40

Packaging Hospitals FDA Pharmaceutical Companies 40

ISPE

MARCH 6, 2023

Sustainability Definitions for the Pharmaceutical Industry Trudy Patterson Mon, 03/06/2023 - 10:26 Features March / April 2023 Sustainability Definitions for the Pharmaceutical Industry William G. Green Manufacturing for the Pharmaceutical Industry.” while meeting patient needs as a primary goal. 1 European Commission.

Communication 52

Communication Patient Care 52

ISPE

MARCH 7, 2023

Melton, PhD 1 March 2023 The imperative for global action to tackle climate change is clear and the pharmaceutical industry has a key role to play. 1 , 2 The effect to the pharmaceutical industry spans its end-to-end activities, including the residual impact of used and unused medicines on the environment. 1 United Nations.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

AUGUST 30, 2022

A reliable supply of raw materials is critical to maintain a robust supply chain to serve patients globally. The pharmaceutical manufacturing supply chain starts with the raw materials, which are needed to ensure drug availability for patients. Tabetha Bonacci, PhD. Ailsa Surman. Lennard, PhD. Burke, PhD.

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

AUGUST 29, 2022

Postapproval change management of pharmaceuticals is an essential part of life-cycle management but is associated with regulatory challenges. The resulting complexity requires manufacturers to tightly control and manage supply chain activities for commercial products globally to maintain compliance.

Documentation 52

Documentation FDA Communication Packaging 52

ISPE

NOVEMBER 30, 2022

A digital approach to predictive and prescriptive maintenance (PPM) can mitigate the cost of lost production caused by unplanned downtime and improve supply chain resiliency. In the Verdantix Green Quadrant: Asset Performance Management Solutions 2022 Report 3. , 1 ISPE Good Practice Guide for Maintenance; February 11, 2021.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

PharmaShots

FEBRUARY 22, 2023

The global pharmaceutical industry is undergoing transformational changes due to advancements in technological innovations that aim to fundamentally alter how patients are historically accessed, treated, and managed. Case studies of successful pharmaceutical technology projects.

Patient Care 58

Patient Care 58

ISPE

MARCH 15, 2023

Whitford Emily Heffernan, PE Aoife Kelly 1 March 2023 Many emerging tools and technologies support the environmental sustainability of the pharmaceutical industry. Green Manufacturing for the Pharmaceutical Industry.” 7 An integrative (vs. 7 An integrative (vs. 7 An integrative (vs. 1 Circular Economy Practitioner Guide.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52